Stephen Schleicher

Stephen Schleicher has extensive work experience in the field of oncology. Stephen currently serves as the Chief Medical Officer at Tennessee Oncology since January 2022. In addition, they have been working as a Medical Oncologist at Tennessee Oncology since September 2018.

Stephen also holds the position of President at Tennessee Oncology Practice Society starting from January 2021.

Previously, they worked as the Medical Director of Value-Based Care at OneOncology from November 2019 to January 2022.

Stephen began their career as an Internal Medicine Resident at Brigham and Women's Hospital from July 2011 to June 2015. During their medical residency, they had the opportunity to work with various patients and gain valuable experience in the field.

Additionally, they briefly worked as a Summer Associate at McKinsey & Company in June 2014, where they gained exposure to consulting work in the healthcare industry.

Stephen Schleicher completed their Doctor of Medicine (MD) degree at Vanderbilt University School of Medicine from 2006 to 2011. Stephen then pursued an Internal Medicine Residency at Brigham and Women's Hospital from 2011 to 2015. In 2013, Stephen attended Harvard Business School, where they obtained a Master of Business Administration (MBA) degree from 2013 to 2015. Lastly, Stephen completed a medical oncology fellowship at Memorial Sloan Kettering Cancer Center from 2015 to 2018.